BNP PARIBAS FINANCIAL MARKETS - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 196 filers reported holding VIKING THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,186,740
-55.0%
378,206
-34.1%
0.01%
-58.3%
Q2 2023$9,298,202
+131.0%
573,609
+137.2%
0.01%
+100.0%
Q1 2023$4,025,870
+761.0%
241,794
+386.1%
0.01%
+500.0%
Q4 2022$467,584
-44.9%
49,743
+15843.3%
0.00%
Q3 2022$849,000
-94.5%
312
-94.1%
0.00%
Q2 2022$15,323,000
-50.0%
5,302
-48.1%
0.00%
Q1 2022$30,618,000
-74.3%
10,206
-60.6%
0.00%
Q4 2021$119,135,000
+9.5%
25,899
+49.4%
0.00%
Q3 2021$108,832,000
+69.8%
17,330
+61.9%
0.00%
Q2 2021$64,111,000
-70.4%
10,703
-68.8%
0.00%
Q1 2021$216,657,000
+319.8%
34,254
+273.7%
0.00%
Q4 2020$51,605,000
-42.2%
9,166
-40.2%
0.00%
Q3 2020$89,273,000
+29.0%
15,339
+59.8%
0.00%
Q2 2020$69,209,000
-64.7%
9,599
-77.1%
0.00%
Q1 2020$195,858,000
+216.4%
41,850
+442.2%
0.00%
Q4 2019$61,906,000
-8.0%
7,719
-21.1%
0.00%
Q3 2019$67,314,000
+21.2%
9,784
+46.2%
0.00%
Q2 2019$55,535,000
-55.9%
6,691
-47.2%
0.00%
Q1 2019$126,049,000
+408.1%
12,681
+790.5%
0.00%
Q3 2018$24,806,000
+83.6%
1,4240.0%0.00%
Q2 2018$13,514,0001,4240.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders